Isoquinoline sulfonamides have recently been shown to exert novel inhibitory effects on mammalian protein kinases by competitively binding to the ATP substrate site (Hidaka, H., M. Inagaki, S. Kawamoto, and Y. Sasaki, 1984, Biochemistry, 23: 5036-5041). We synthesized a unique analog of the previously reported compounds, 145-isoquinolinesulfonyl) piperazine (C-I), in order to assess the role of protein kinases in modulating the agonist-stimulated oxidative burst of human polymorphonuclear leukocytes (PMN).
Introduction
Stimulated polymorphonuclear leukocytes (PMN)' reduce molecular oxygen to reactive metabolites, such as superoxide (O°) and hydrogen peroxide (H202) (1) . This respiratory burst is crucial to adequate host defense against bacteria. The enzymatic systems responsible for activation of the respiratory burst are only currently being defined. The response occurs in PMN stimulated by a variety of agonists. Possible physiologic stimuli include COa, bacterial chemotactic factors, and certain arachidonate metabolites such as leukotriene B4, as well as phagocytosis
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1. Abbreviations used in this paper: C-I, 145-isoquinolinesulfonyl) piperazine; Cyto B, cytochalasin B; FMLP, N-formyl-methionyl-leucylphenyl-alanine; O2, superoxide anion; OAG, I-oleoyl-2-acetyl-glycerol;
PKC, protein kinase C; PMA, phorbol myristate acetate. (2) . Stimulated neutrophils demonstrate increased oxygen consumption, release of O-and H202, and oxidation of NADPH with resultant stimulation of glucose metabolism by the hexose monophosphate shunt. The enzyme (or enzyme complex) involved in the respiratory burst has been termed "NADPH oxidase", and may involve transfer of electrons from NADPH to a flavoprotein, thence to ubiquinone, thence to a b cytochrome, and finally to 02 (3) (4) (5) . Before stimulation, the components of this electron transport chain appear to be present in intracellular organelle(s) and are translocated to the membrane fraction after application of stimulating agonists (6 (16) . Stimulation of PMN with PMA results in a rapid apparent translocation of cytosolic PKC to the particulate fraction in correlation with activation ofNADPH oxidase (8) . Diacylglycerols have been suggested as the natural activators of PKC (17), and the synthetic diacylglycerol, 1-oleoyl-2-acetyl-glycerol (OAG) activates PKC and stimulates the respiratory burst (9) . These data strongly suggest that activation of PKC can lead to activation of NADPH oxidase, possibly by phosphorylating a component of the oxidase enzyme system.
Hidaka and co-workers have recently described the synthesis and properties of a novel class of mammalian protein kinase inhibitors based on isoquinoline sulfonamides (18) . These agents possess potent inhibitory activity against cyclic AMP (cAMP) and cyclic guanosine 3'5'-monophosphate-dependent protein kinases, as well as PKC, by competitively interacting with the ATP binding site of the enzymes. In contrast to the napthalene sulfonamides (e.g., W-7), the isoquinoline sulfonamides do not inhibit calmodulin-dependent kinase at low concentrations. The most potent of the inhibitors tested, H-7, has been used to examine the role ofPKC in the PMA-stimulated release ofplatelet serotonin (19). Since PKC plays a potentially key role in modulating the oxidative response of neutrophils, it was of interest to study the pharmacologic effect of isoquinoline sulfonamides in this system. In this communication we report the synthesis and properties of an isoquinoline sulfonamide, 1-(5-isoquino-linesulfonyl) piperazine (C-I), as a probe ofthe human neutrophil respiratory burst.
Methods
Synthesis and characterization ofC-I. Isoquinoline-5-sulfonic acid (1.5 g) (Pfaltz and Bauer Inc., Stamford, CT) and phosphorous pentachloride (1.75 g) (Aldrich Chemical Inc., Co., Milwaukee, WI) were combined in a round-bottomed flask with a magnetic stirring bar and a reflux condenser. The heterogeneous reaction mixture was heated under an atmosphere of nitrogen until it melted (oil bath temperature, 2 10WC) and reflux begun. The resulting yellow liquid was heated for an additional 15 min and then cooled to room temperature, whereupon the reaction mixture solidified. Small pieces of the resulting solid were carefully added to H20-ice (250 ml). The aqueous mixture was then extracted with ether (2 X 200 ml) and then with ethyl acetate (2 X 250 ml). The combined organic extracts were washed with brine, dried (MgSO4), and evaporated in vacuo to yield 0.795 g of yellow crystalline solid. Recrystallization of the crude product from toluene gave 0.675 g light-yellow crystalline plates ofisoquinoline-5-sulfonyl chloride. Melting point was 104-105°; precise mass spectra calculated for C9H6NSClO2 m/e = 226.9, was 226.9.
The isoquinoline-5-sulfonyl chloride was reacted with piperazine exactly as described by Hidaka et al. (18) to yield C-I, with an overall yield of 84%. Crystalline C-I possessed a melting point of 132-1340C; mass spectra calculated as m/e = 277, found 277. The nuclear magnetic resonance and infrared spectra, as well as elemental analysis, confirmed the chemical structure (data not shown).
PKC assay and determination ofinhibitor constant. PKC was assayed in subcellular fractions of human PMN as previously described (7, 8) . Briefly, in a final volume of 0.25 ml, reaction mixtures contained 35 mM Tris-HCl (pH 7.5), 10 mM magnesium chloride, 0.6 mM added calcium chloride, 0.4 mM EGTA, 0.4 mM phenylmethysulfonyl fluoride, 0.01% Triton X-100, 2 mM 2-mercaptoethanol, 20 ug/ml phosphatidylserine, 2 jig/ml diolein, 10 or 50 qM (,y-32P)-ATP (New England Nuclear, Boston, MA), 40,g of histone H-1, and 10-20 jig of neutrophil fraction. Unless otherwise indicated, all reagents were obtained from Sigma Chemical Co., St. Louis, MO. Reactions were conducted for 5 min at 30°C in the presence or absence of added Ca2' and lipids and terminated by the addition of ice-cold 25% trichloroacetic acid followed by the addition of albumin as a carrier. The precipitates were collected by filtration on type HA filters, 0.45 ,m (Millipore Corp., Bedford, MA), washed, and subjected to scintillation counting. The inhibitor constant (K1) was determined for compound C-I as described by Dixon (20) . cAMPdependent protein kinase was assayed under the same conditions except that added Ca2' and lipids were omitted and assays were conducted in the presence or absence of 10 jM cAMP (Sigma Chemical Co.).
Isolation ofhuman PMN neutrophils and subcellularfractions. Neutrophils were isolated from peripheral blood of healthy donors by dextran sedimentation and Ficoll-Hypaque centrifugation as previously described (21) . Following hypotonic lysis ofcontaminating erythrocytes, cells were resuspended in Hank's balanced salt solution (HBSS) containing 4.2 mM sodium bicarbonate and 10 mM Hepes, pH 7.4, and utilized for either intact cell functional studies or for isolation of subcellular fractions.
For isolation of neutrophil subcellular fractions, cells at 5 X 107/ml were either not stimulated or stimulated with 1.6 X 10-7 M PMA for 30 s, diluted 10-fold with ice-cold HBSS, sedimented, and resuspended in an extraction buffer containing 50 mM Tris-HCl, 10 mM 2-mercaptoethanol, 2 mM phenylmethylsulfonyl fluoride, and 2 mM EGTA, pH 7.5 (8, 22) . Cells were sonicated, centrifuged at 500 g to remove unbroken cells and nuclei, then centrifuged at 180,000 g for 90 min (7, 8) . The 1 80,000-g supernatant was saved and the pellet was resuspended in the same extraction buffer plus 0.1% Triton X-100. Both fractions were stored at 0-40C.
Measurement ofsuperoxide anion release and oxygen uptake. The release of O2 by isolated intact PMN was assessed as the superoxide dismutase-inhibitable reduction ofcytochrome c as previously described (23 
Results
Characterization of C-I. The crystalline C-I preparation was characterized by elemental analysis, infrared spectroscopy, 1-H nuclear magnetic resonance spectroscopy, and mass spectrum analysis (see Methods). The sulfonamide was assayed according to the method of Dixon (20) as an inhibitor of human neutrophil PKC and cAMP-dependent protein kinase in cytosolic fractions prepared from unstimulated human peripheral PMN. As shown in Fig. 1 , C-I was a potent inhibitor of both enzymes, with a Ki value of =20 ,M for PKC and -3 ,uM for cAMP-dependent protein kinase. In addition, C-I inhibited the particulate-bound protein kinase obtained by PMA-stimulation of intact cells (8) with a 50% inhibition concentration of -24 ,uM (data not shown). These results confirm and extend the observations of Hidaka et al. (18) to the kinases present in the human PMN.
Since PMA is a potent agonist of the respiratory burst of neutrophils and since it directly activates PKC, it was of interest to ascertain whether the response of PMN to PMA could be inhibited by compound C-I. As shown in Fig. 2 A the release of°2 by human PMN stimulated with 30 ng/ml PMA was inhibited in a concentration-dependent fashion by C-I. The 50% inhibition concentration value of this inhibition was 64 ,uM. Inhibition by the sulfonamide did not appear to be caused by competition with PMA, since the mean percentage inhibition by 103 ,uM C-I did not change over a 10-fold range of PMA concentrations yielding maximal°2 release (3 ng/ml = 50% inhibition, n = 3; 10 ng/ml = 46% inhibition, n = 6; 30 ng/ml = 51% inhibition, n = 12). This conclusion is further supported by one additional experiment, performed in triplicate, in which°2 release induced by PMA at concentrations of 10, 30, 100, 300, and 1,000 ng/ml was inhibited 44%, 40%, 39%, 50%, and 40%, respectively, by 103 jM C-I.
The effect of C-I on oxygen consumption induced by PMA was also examined. Results indicated that the time to onset of stimulated consumption (the lag time) was unchanged, but the The proposed natural analogues of PMA in vivo are diacylglycerols. OAG has been particularly useful in implicating PKC in stimulus-response coupling since, unlike diolein, it can penetrate intact cells (17). Fig. 1 B demonstrates that the release of O2 by human neutrophils stimulated with various concentrations of synthetic OAG is also susceptible to inhibition with C-I. Thus, these data taken together indicate that activation of cytosolic PKC is a necessary step in the activation ofthe respiratory burst in human PMN induced by PMA and OAG.
Effect ofC-I on stimulation ofneutrophils by C5a and FMLP. C5a and FMLP are potent agonists of PMN function. Both peptides have been shown to function through binding to receptors present on the plasma membrane (26, 27). The mechanism of signal transduction is unknown; however, the binding of both peptides is followed by a rapid and bnef elevation of intracellular cAMP (28). In addition, FMLP has been shown to induce a rapid rise in cytosolic calcium concentration (29) and stimulation ofpolyphosphoinositide turnover (30 As presented in Fig. 3 A, O2 release in response to 300 nM FMLP was not inhibited by the isoquinoline sulfonamide, C-I (1-206 ,M), either in the presence or absence of Cyto B. Similarly, the dose-response profile of C5a was unaffected by 103 ,sM C-I (Fig. 2 B) . If 58-52
